Search For "phase iii trials"
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 3 years, 11 months ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Updated : 4 years, 2 months ago IST
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Read More
AstraZeneca booster dose works against Omicron, says Oxford lab study
Updated : 4 years, 5 months ago IST
London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of
Read More
Glenmark to conduct phase III trials of nasal spray it claims to be effect
Updated : 4 years, 11 months ago IST
New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19.
Read More
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
'Covaxin shows overall 78 pc interim efficacy, 100 pc efficacy against sev
Updated : 5 years, 1 month ago IST
Hyderabad (Telangana) [India], April 21 (ANI): Covaxin, India's indigenous vaccine against COVID-19 demonstrated "overall interim clinical efficacy" of 78 per cent and 100 per cent efficacy against "severe COVID-19 disease" in Phase-III trials, informed Bharat Biotech and Indian Council of M
Read More
Unseemly haste risks jeopardising India's good reputation: Shashi Tharoor
Updated : 5 years, 5 months ago IST
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
Read More
Bharat Biotech starts phase III trials for COVAXIN
Updated : 5 years, 6 months ago IST
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Read More
Keeping Pfizer's COVID-19 vaccine at low temperatures will be challenging
Updated : 5 years, 6 months ago IST
New Delhi [India], November 11 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's COVID-19 vaccine phase III trials are very encouraging but preserving it at very low temperatures, -70 degree C, will
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 5 years, 8 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More